News
Greenovation transforms into Eleva
May 18, 2020
Press Release
Greenovation is launching its supreme moss-based development platform with a new business model and is transforming into a new company, Eleva.
Eleva secures up to EUR 60 million to advance a drug candidate, appoints new board member
January 6, 2021
Press Release
Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of Covid-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of Covid-19. Eleva has developed factor H previously for a different indication and taken it through pre-clinical stages.
Eleva entwickelt mit Geld aus Heilbronn Covid-19-Wirkstoff
June 18, 2020
Press Clipping
Stimme.de – Unterstützt vom Zukunftsfonds Heilbronn entwickelt die Biotech-Firma Eleva einen Wirkstoff, der bei Covid-19-Patienten zum Einsatz kommen könnte. Gezüchtet wird er in Moos.